1. Home
  2. MRC vs STOK Comparison

MRC vs STOK Comparison

Compare MRC & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRC
  • STOK
  • Stock Information
  • Founded
  • MRC 1921
  • STOK 2014
  • Country
  • MRC United States
  • STOK United States
  • Employees
  • MRC N/A
  • STOK N/A
  • Industry
  • MRC Industrial Machinery/Components
  • STOK Biotechnology: Pharmaceutical Preparations
  • Sector
  • MRC Industrials
  • STOK Health Care
  • Exchange
  • MRC Nasdaq
  • STOK Nasdaq
  • Market Cap
  • MRC 1.1B
  • STOK 1.3B
  • IPO Year
  • MRC 2012
  • STOK 2019
  • Fundamental
  • Price
  • MRC $13.98
  • STOK $31.63
  • Analyst Decision
  • MRC Buy
  • STOK Strong Buy
  • Analyst Count
  • MRC 3
  • STOK 7
  • Target Price
  • MRC $15.67
  • STOK $30.83
  • AVG Volume (30 Days)
  • MRC 542.1K
  • STOK 1.4M
  • Earning Date
  • MRC 11-06-2025
  • STOK 11-12-2025
  • Dividend Yield
  • MRC N/A
  • STOK N/A
  • EPS Growth
  • MRC N/A
  • STOK N/A
  • EPS
  • MRC N/A
  • STOK 0.91
  • Revenue
  • MRC $2,945,000,000.00
  • STOK $199,893,000.00
  • Revenue This Year
  • MRC $5.81
  • STOK $416.54
  • Revenue Next Year
  • MRC $5.43
  • STOK N/A
  • P/E Ratio
  • MRC N/A
  • STOK $34.83
  • Revenue Growth
  • MRC N/A
  • STOK 1218.82
  • 52 Week Low
  • MRC $9.23
  • STOK $5.35
  • 52 Week High
  • MRC $15.59
  • STOK $38.69
  • Technical
  • Relative Strength Index (RSI)
  • MRC 48.45
  • STOK 59.50
  • Support Level
  • MRC $13.14
  • STOK $31.30
  • Resistance Level
  • MRC $14.55
  • STOK $33.88
  • Average True Range (ATR)
  • MRC 0.43
  • STOK 2.56
  • MACD
  • MRC 0.06
  • STOK -0.45
  • Stochastic Oscillator
  • MRC 52.43
  • STOK 31.60

About MRC MRC Global Inc.

MRC Global Inc distributes pipes, valves, fittings, and other infrastructure products and services to diversified gas utility, energy, and industrial end-markets. It provides supply chain solutions, technical product service and a digital platform for customers globally. It offers a range of PVF, oilfield supply, valve automation and modification, measurement, instrumentation, and other general and specialty products. Its geographical segments include the United States and International. It generates the majority of its revenue from the United States.

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Share on Social Networks: